Wed 19 Jun 13

Transparency bill review

A SENATE Committee review of the Therapeutic Goods Amendment (Pharmaceutical Transparency) Bill 2013 has recommended that it not be passed, because it would “significantly curtail legitimate interactions between therapeutic product suppliers and healthcare professionals”.

---

Wed 19 Jun 13

TGA plans OTC ad reforms

THE Therapeutic Goods Administration has outlined proposals to reform the current “pre-approval” system for advertisements for OTC products, as well as improve the efficiency of the complaints handling process.

---

Tue 18 Jun 13

Guild, PSA unite on CPD cap

THE Pharmaceutical Society of Australia and the Pharmacy Guild have issued a joint statement about their serious concerns over the impact on professional standards of the government’s proposed $2000 cap on self-education expenses.

---

Tue 18 Jun 13

Guild prescribing potential

THE Pharmacy Guild has suggested that pharmacists could potentially take on “an enhanced role in patient care as an authorised prescriber,” as part of its response to the Review of PBS Medicines Used to Treat Asthma in Children.

---

Mon 17 Jun 13

EMA codeine restrictions

THE European Medicines Agency has recommended changes to address safety concerns about the use of codeine in children, including not using the drug at all in those who undergo surgery for the removal of tonsils or adenoids.

---

Mon 17 Jun 13

Diabetes MedsCheck study

FOURTEEN NSW community pharmacies are taking part in a new research initiative which aims to evaluate the effectiveness of the govt’s Diabetes MedsCheck service.